Clinical Trial Update: Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating safety, tolerability, and efficacy of MTP-131 for mitochondrial myopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitochondrial Myopathy

Drugs mentioned

• MTP-131 (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Mitochondrial Myopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-27